GEN-004: Phase I data

Top-line data from a double-blind, placebo-controlled, dose-escalation, U.S. Phase I trial in 90 healthy volunteers showed that 10, 30 and 100 ug GEN-004 every 4 weeks for up to 3 doses with or withou...